58
Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression David L. Walker Gayla Y. Paschall Michael Davis

Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Embed Size (px)

Citation preview

Page 1: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

• Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning and expression– David L. Walker– Gayla Y. Paschall– Michael Davis

Page 2: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Context switch experimentResults?

• Page 126 right column on bottom

• During training, background noise was off and a 150 lux houselight was on.

• Olfactory stimulus

Page 3: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Abbreviations• NBQX……..1,2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo[f]quinoxa-line-

7-sulfonamide disodium salt– 3 μg/side

• AP5……….. DL-2-amino-5-phospho-nopentanoic acid – 2.5 μg/side

• ACSF……..artificial cerebrospinal fluid

• AMPA…….. amino-3-hydroxy-5-methylisoxazole-4-propionic acid• NMDA………N-methyl-D-aspartate

• CS…………conditioned stimulus• 95 db………accustic stimulus

Page 4: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Classical fear conditioning

Page 5: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

The Amygdala

• key role in auditory and visual stimuli fear conditioning (learning) and fear expression (display)

• exact role in learning is unclear– neural plasticity in aversive learning

paradigms or– a brain area that modulates memory storage

elsewhere

Page 6: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

The Amygdala 2

• Basolateral Amygdala– mediates fear responses to olfactory CSs perhaps via afferents

from the perirhinal cortex– NBQX or AP5

• disrupt the facilitatory effects of sustained bright light on startle

• Medial Amygdala– may participate in olfactory fear conditioning – receives a prominent olfactory input relative to other modalities

• Central Amygdala– NBQX or AP5

• no change

Page 7: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Visual and auditory stimuli

Olfactory stimuli

Page 8: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

GOALS

• Basolateral amygdala– confirm the involvement in fear expression to

an olfactory CS– determine if if participates in olfactory fear

learning

• Medial amygdala– evaluate the contribution to both

Page 9: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Materials and methods and methods

Page 10: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

animals

• Male Sprague-Dawley rats – Pre surgery:

• group-housed (4 per cage) in 45 x 20 x 24-cm (depth width height) polycarbonate cages

– Surgery weight:• 275-350g

– Post surgery: • individually housed, in 20 x 19 x 24-cm hanging

wire-mesh cages

Page 11: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Surgery

• 22-gauge guide cannulae bilaterally into– basolateral amygdala – medial amygdala

• A minimum of 8 d elapsed between surgery and the behavioral procedures

Page 12: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Histology

• Rats were terminally sampled– 40-μm coronal sections stained with cresyl violet– placement judged by a scorer blind to the animal’s

group assignment and behavioral data– cannula tips were required to be within or no further

than 0.5 mm from the intended target • Experiments 1 & 2

– basolateral amygdala complex

• Experiments 3 & 4– medial amygdala nucleus

Page 13: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning
Page 14: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning
Page 15: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning
Page 16: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Training cages

• Rats were trained and tested in two identical Plexiglas and wire-mesh cages– The floor: four 6.0-mm

diameter stainless steel bars spaced 18 mm apart.

Page 17: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Acclimation session(2 consecutive days)

• rats were placed into the test cages– 5 min acclimation

• 30 startle-eliciting noise bursts – (onset-to-onset interstimulus interval = 30

sec).

• rats were sorted into different treatment groups

Page 18: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Measuring of startle

• Accelerometer at the bottom if the cage

• Startle amplitude– maximal peak-to-peak voltage during the first 300

msec after onset of the startle-eliciting noise burst– evoked by 50-msec white-noise bursts

• Background noise (60-dB wideband white-noise)

Page 19: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning
Page 20: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Fear conditioning(Within three days of the final acclimation session)

• 5 min acclimation

• Experiments 1-4A– five odor-shock pairing in a 4 min interval

• Experiment 4B– five light-shock pairings in a 4 min interval

• For each pairing, the 0.5-sec shock was delivered 3.5 sec after onset of the 4.0-sec CS.

• The unconditioned stimulus for all experiments was a 0.5-sec 0.4-mA scrambled floor-bar shock.

Page 21: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Olfactory stimulus

• continuous flow of air

• stimulus– for 4 sec, scent of 20 ml of 5% amyl acetate in

propylene glycol solution– mixed in a 3:5 ratio with clean air before flowing into

the cage

• The chamber was actively exhausted – Total volume turnover every 25 sec

Page 22: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Visual stimulus

• Stimulus– A 4-sec light on produced by an 8-W (140 lux)

fluorescent bulb located 10 cm behind each cage

Page 23: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Drugs and infusion procedure

• Rats were infused– NMDA receptor antagonist AP5– AMPA/kainate receptor antagonist NBQX– ACSF

• Infusions – 0.25 μL/min, 0.5 μL total volume

Page 24: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Drugs and infusion procedure

• infusion

• Pre-training– 15 min rest?– Animal placed in test cage– 5 min later – first CS-shock pairing

• Pre-test– Animal placed in test cage– Start of test 20 min later

Page 25: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Fear-potentiated startle test(48 h later returned to the training chamber)

• 5 min acclimation

• Baseline– 30 startle-eliciting noise bursts (every 30 sec)

• Test– 40 test trials consisting of 10 repetitions of a single CS test trial – three noise-alone test trials

• The noise burst was presented 3.5 sec after onset of – the odor (Experiments 1-4A)– light (Experiment 4B)

Page 26: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Recap Timeline

• Surgery– 8 day recovery

• Baseline sorting (2 days)– 3 day recovery

• Training– 2 day recovery

• Testing

Page 27: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Recap injections

• Fear conditioning– Injection (AMPA/kainate or NMDA receptor

antagonists) – After 15 min wait moved to training cage– 5 min wait till start

• Fear expression– Injection– Moved to testing cage right afterwards– 20 min wait till start

Page 28: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Statistical analyses

• mean startle amplitude (%) – noise-alone to CS test

• baseline startle (reflect context conditioning)– pre-conditioning to the post-conditioning

• analyzed using ANOVA and/or two-tailed t-tests

• criterion for significance was P < 0.05.

Page 29: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Results

Page 30: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Experiments 1A and 1B

NMDA receptor blockade in the basolateral amygdala

Page 31: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

AP5 prior to training

• Mean footshock reactivity (S.E.M.) during training– ACSF [N = 5] (1188 ±

295) – AP5 [N = 7] (1048 ±

301)

• SIGNIFICANT– t(11) = 2.92.– did not evaluate NBQX

Page 32: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

AP5 prior to testing

• test days separated by 48h

• AP5 day 2 [N = 3]– 25.1 ± 4.9 ACSF– 56.4 ± 27.7 AP5

• AP5 day 1 [N = 5]– 88.7 ± 26.2 AP5 – 91.0 ± 50.2 ACSF

• NOT SIGNIFICANT– t(7) = 0.44,

Page 33: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

What we got till now…

• BASOLATERAL AMYGDALA– Acquisition of a conditioned fear stimulus

requires NMDA receptor activity.

– Expression of a conditioned fear stimulus does not require NMDA receptor activity.

Page 34: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Experiment 2

AMPA/kainate receptor blockade in the

basolateral amygdala

Page 35: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

NBQX prior to testing

• test days separated by 48h

• ACSF on day 1 [N = 7]– 127.6 ± 39.3

• ACSF on day 2 [N = 5]– 89.6 ± 34.4

• The difference was not significant (P = 0.41).

• SIGNIFICANT – t(11) = 4.65.

Page 36: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

What we got till now…

• BASOLATERAL AMYGDALA– Acquisition of a conditioned fear stimulus

requires NMDA receptor activity.

– Expression of a conditioned fear stimulus does not require NMDA receptor activity.

– Expression of a conditioned fear stimulus requires AMPA/kainate receptor activity

Page 37: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Experiment 3

AMPA/kainate and NMDA receptor blockade in the

medial amygdala

Page 38: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

AP5 or NBQX prior to training

• Experiment 3– ACSF [N = 7]– AP5 [N = 8] – NBQX [N = 6]

• NOT SIGNIFCANT– but ACSF is really low – Normal: 92.4 ± 12.

Page 39: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

What we got till now…

• BASOLATERAL AMYGDALA– Acquisition of a conditioned fear stimulus requires

NMDA receptor activity.

– Expression of a conditioned fear stimulus does not require NMDA receptor activity.

– Expression of a conditioned fear stimulus requires AMPA/kainate receptor activity.

• MEDIAL AMYGDALA– Acquisition of a conditioned fear stimulus does not

require NMDA or AMPA/kainate receptor activity.

Page 40: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Experiments 4A and 4B:

AMPA/kainate receptor antagonist into the

medial amygdala

Page 41: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

NBQX prior to odor testing

• Experiment 4a– ACSF [N = 7]– NBQX [N = 10]

• Independet sample t-test

• SIGNIFICANT– t(15) = 2.41.

Page 42: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

What we got till now…

• BASOLATERAL AMYGDALA– Acquisition of a conditioned fear stimulus requires NMDA

receptor activity.

– Expression of a conditioned fear stimulus does not require NMDA receptor activity.

– Expression of a conditioned fear stimulus requires AMPA/kainate receptor activity.

• MEDIAL AMYGDALA– Acquisition of a conditioned fear stimulus does not require

NMDA or AMPA/kainate receptor activity.

– Expression of a conditioned fear stimulus does require AMPA/kainate receptor activity.

Page 43: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

NBQX prior to light test

– ACSF [N = 8]– NBQX [N = 13]

• SIGNIFICANT– t(19) = 2.26– Did not do it with AP5

Page 44: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

ACSF vs. DrugSight vs. odor

• ANOVA (Experiment 4A & B):– Significant effect of drug treatment

• F(1,34) = 16.02

– Not significant effect of modality (light vs odor)

Page 45: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

What we got till now…

• BASOLATERAL AMYGDALA– Acquisition of a conditioned fear stimulus requires NMDA

receptor activity.

– Expression of a conditioned fear stimulus does not require NMDA receptor activity.

– Expression of a conditioned fear stimulus requires AMPA/kainate receptor activity.

• MEDIAL AMYGDALA– Acquisition of a conditioned fear stimulus does not require

NMDA or AMPA/kainate receptor activity.

– Expression of a conditioned fear stimulus does require AMPA/kainate receptor activity. (olfactory or visual)

Page 46: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Break?

Page 47: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Treatment effects on “baseline” startle amplitude

• NBQX – could block the acquisition of the

context in which a stimulus takes place

• Compare 30 noise-alone trials– Pre-training (grouping of baselines) – pre-testing 30 noise alone trials

• ANOVA– significant Treatment effect, F(1,34) =

4.93, not a significant Modality or interaction effect

• The absolute level of startle prior to conditioning was somewhat, although not significantly, lower in the groups that later received NBQX (i.e., vs. the groups that later received ACSF).

Page 48: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

• Comparison– Pre-test NBQX to ACSF– Pre-training AP5 to ACSF

• pre- to post-conditioning changes in baseline startle amplitude

• no obvious effect on the pre- to post-conditioning increases

Page 49: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Follow up experiments (context switch experiment)

• different chamber– did not show the same pre-training to post-

training increase. • 239.0 ± 37.6 prior to conditioning• 235.4 ± 46.7 after conditioning

Page 50: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Specific vs. nonselective• NBQX infused into the medial nucleus of the amygdala

– might have specifically disrupted the influence of context on startle– might have depressed startle nonselectively and simply masked the

influence of context

• Evaluated the effect of NBQX infusions in untrained animals. [N = 9]– medial nucleus of the amygdala (One week rest)– 30 95-dB noise bursts– 30 intermixed 110-dB noise bursts.

• were included to ensure that a negative finding could not be attributed to baseline-dependent NBQX effects

• 24 h and 72 h later (the order of treatments was counterbalanced) – ACSF or NBQX

• 24 and 72 h later and were retested

Page 51: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

• NOT SIGNIFICANT

• => NBQX causes a specific disruption of the pre- to post-conditioning increase

Page 52: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Influence of cannula placement on the magnitude of the NBQX effect

• medial amygdala lies just – medial to the basomedial and cortical amygdala

nuclei– drugs infused into the medial nucleus might diffuse

dorsally along the cannula track where they – might also influence the central nucleus of the

amygdala (where NBQX infusions have previously been shown to disrupt fear-potentiated startle to a visual CS,

• we considered the possibility that the effects of pre-test infusions into the medial nucleus might be mediated by actions elsewhere.

Page 53: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

• Experiment 4A– 10 NBQX-infused rats with

bilateral placements– 4 rats with only a single

cannula in the medial amygdala

• SIGNIFICANT– t(12) = 3.21

• => Effect of NBQX is anatomically specific and require bilateral inactivation of the medial nucleus of the amygdala

Page 54: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

placement-effect correlations rats in Experiment 4A

• the total distance of both cannula tip to either the

– medial, – basomedial, – cortical, or – central amygdala nuclei

• The summed distance was entered into a correlation analysis using percent potentiation as the correlated variable.

• SIGNIFICANT correlation for medial nucleus

– r = 0.82

• NOT SIGNIFICANT for other 3 areas– Central: r = 0.15– Cortical: r = 0.29– Basomedial: r = 0.45

Page 55: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

• No placement correlations in visual experiment– To few animals

• For fear-potentiated startle to context,– No alteration if NBQX was injected

• Bilateral 8 ± 11 [N = 22] % potentiation• Unilateral 1 ± 16 [N = 7] % potentiation

• No correlation between percent potentiation and proximity to any of the four structures examined.

Page 56: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

What we got till now…• BASOLATERAL AMYGDALA

– Acquisition of a conditioned fear stimulus requires NMDA receptor activity, which appears to be involved in connecting contextual events.

– Expression of a conditioned fear stimulus does not require NMDA receptor activity.

– Expression of a conditioned fear stimulus requires AMPA/kainate receptor activity.

• MEDIAL AMYGDALA– Acquisition of a conditioned fear stimulus does not require NMDA or

AMPA/kainate receptor activity.

– Expression of a conditioned fear stimulus does require AMPA/kainate receptor activity. (olfactory or visual)

Page 57: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

BasolateralAmygdala

NMDAAMPA (not NMDA)

MedialAmygdala

(Not NMDA or AMPA)AMPA

BNST

CentralAmygdala

AMPA?AMPA?

primary acoustic startle circuit

•do not require conditioning to evoke fear/anxiety•conditioning to appetitive stimuli

AcquisitionExpression

Conditioned olfactory fear/anxiety stimulus

Visual Stimuli

Page 58: Glutamate receptor antagonist infusions into the basolateral and medial amygdala reveal differential contributions to olfactory vs. context fear conditioning

Fin(DONE)